Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer

Journal of Urology

Volumn 194, Issue 6, 2015, Pages 1624-1630

  Zumsteg, Zachary S ^b   Spratt, Daniel E ^b   Romesser, Paul B ^b   Pei, Xin ^b   Zhang, Zhigang ^b   Kollmeier, Marisa ^b   McBride, Sean ^b   Yamada, Yoshiya ^b   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

lymph nodes; prostatic neoplasms; radiotherapy; recurrence; treatment failure

Indexed keywords

AGED; ARTICLE; BONE; CANCER MORTALITY; CANCER RECURRENCE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE ESCALATION; SEMINAL VESICLE; BLOOD; BONE TUMOR; CANCER GRADING; CANCER STAGING; DIAGNOSIS; LYMPH NODE METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSE; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL; TUMOR RECURRENCE;

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; BIOMARKERS, TUMOR; BONE NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEMINAL VESICLES; SURVIVAL ANALYSIS;

EID: 84947252621     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.06.100     Document Type: Article

References (26)

1. M.J. Zelefsky, J.A. Eastham, A.M. Cronin, and et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix J Clin Oncol 28 2010 1508
2. M.R. Cooperberg, A.J. Vickers, J.M. Broering, and et al. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer Cancer 116 2010 5226
3. K.G. Nepple, A.J. Stephenson, D. Kallogjeri, and et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity Eur Urol 64 2013 372
4. Z.S. Zumsteg, and M.J. Zelefsky Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care? Lancet Oncol 13 2012 e259
5. P.L. Nguyen, and A.V. D'Amico Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials J Clin Oncol 26 2008 2055
6. M. Roach 3rd Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer, and confusion about the results of the randomized trials J Clin Oncol 26 2008 3816
7. T.J. Wilt, M.K. Brawer, K.M. Jones, and et al. Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203
8. A. Bill-Axelson, L. Holmberg, H. Garmo, and et al. Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 2014 932
9. D. Pucar, T. Sella, and H. Schoder The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery Curr Opin Urol 18 2008 87
10. A.C. Westphalen, F.V. Coakley, M. Roach 3rd, and et al. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection Radiology 256 2010 485
11. J. Mohler, R.R. Bahnson, B. Boston, and et al. NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162
12. M.J. Zelefsky, H. Chan, M. Hunt, and et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 2006 1415
13. Z.S. Zumsteg, D.E. Spratt, P.B. Romesser, and et al. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy Eur Urol 67 2015 1009
14. C.U. Jones, D. Hunt, D.G. McGowan, and et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 2011 107
15. M.J. Zelefsky, V.E. Reuter, Z. Fuks, and et al. Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer J Urol 179 2008 1368
16. A. Widmark, O. Klepp, A. Solberg, and et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial Lancet 373 2009 301
17. P. Warde, M. Mason, K. Ding, and et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial Lancet 378 2011 2104
18. D.E. Spratt, L.M. Scala, M. Folkert, and et al. A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer Brachytherapy 12 2013 428
19. C.A. Lawton, M. DeSilvio, M. Roach 3rd, and et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions Int J Radiat Oncol Biol Phys 69 2007 646
20. P. Pommier, S. Chabaud, J.L. Lagrange, and et al. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01 J Clin Oncol 25 2007 5366
21. M. Bolla, G. Van Tienhoven, P. Warde, and et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study Lancet Oncol 11 2010 1066
22. M.V. Pilepich, K. Winter, C.A. Lawton, and et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31 Int J Radiat Oncol Biol Phys 61 2005 1285
23. M. Roach 3rd, K. Bae, J. Speight, and et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610 J Clin Oncol 26 2008 585
24. J.W. Denham, A. Steigler, D.S. Lamb, and et al. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial Lancet Oncol 12 2011 451
25. A.V. D'Amico, M.H. Chen, A.A. Renshaw, and et al. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289
26. E.H. Kennedy, J.M. Taylor, D.E. Schaubel, and et al. The effect of salvage therapy on survival in a longitudinal study with treatment by indication Stat Med 29 2010 2569